Of 970 sexually transmitted disease (STD) patients enrolled at the Comprehensive Health
Centre, Kingston, Jamaica, between November 1990 and January 1991, 710 (73%, 333 …

Current efforts to test blood donors and other persons for exposure to the human T cell
lymphotropic virus type III (HTLV-III), the etiologic agent of the acquired immunodeficiency …

T-lymphocyte subsets and human T-cell lymphotropic virus type III antibody prevalence were
studied in African patients with the acquired immunodeficiency syndrome (AIDS) or AIDS …

The acquired immunodeficiency syndrome (AIDS) epidemic shows no sign of waning.
Recent calculations suggest that several hundred thousand asymptomatic people may have …

The first cases of AlDS in black Africans without any previously known risk factors were
reported in March 1983. By April 1984, 24 such patients were reported in France: we studied …

Human immunodeficiency virus (HIV-1)-infected subjects with acquired immunodeficiency
syndrome (AIDS) are often infected with multiple pathogens. In particular, HTLV-I and HTLV …

PIP: Sera from 1029 subjects from Alexandria, Egypt were tested for antibodies to HTLV-1
and HIV-1 by ELISA and confirmatory immunoprecipitation assay. The sera were from 866 …

A matched-pair, cross-sectional study of lymphocyte and serological parameters associated
with acquired immune deficiency syndrome (AIDS) in 189 randomly chosen, ostensibly …

The authors estimate that in July 1985, when 5909 living cases of AIDS were known in the
USA, there were 1 765 470 individuals infected with the causative agent, HTLV-III. This …

The objective of this study is to describe participants in the Multicenter AIDS Cohort Study
(MACS) with incident infection due to the human immunodeficiency virus type-1 (HIV-1) in …